Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project

  • Howayda S Abd El All1Email author,

    Affiliated with

    • Amany Refaat2 and

      Affiliated with

      • Khadiga Dandash3

        Affiliated with

        Infectious Agents and Cancer20072:12

        DOI: 10.1186/1750-9378-2-12

        Received: 10 March 2007

        Accepted: 04 July 2007

        Published: 04 July 2007

        Abstract

        Background

        Data from Egyptian studies provide widely varying estimates on the prevalence of pre-malignant and malignant cervical abnormalities and human papilloma virus (HPVs) infection. To define the prevalence and risk factors of pre-invasive and invasive cervical cancer (cacx), a community based full-scale cross sectional, household survey including 5453 women aged between 35 and 60 years was conducted.

        Methods

        The study period was between February 2000 and December 2002. Initially, conventional Papanicolaou (Pap) smears were evaluated using the Bethesda system (TBS), followed by colposcopic guided biopsy (CGB) for all epithelial abnormalities (EA). In a third step, HPV was tested on all EA by in-situ hybridization (ISH) using first the broad spectrum HPV probe recognizing HPVs 6, 11, 16, 18, 30, 31, 35, 45, 51 and 52 followed by subtyping with probes 6/11, 16/18 and 31/33. Lastly, unequivocal cases were immunostained for herpes simplex type-2 (HSV-2), cytomegalovirus (CMV), and human immunodeficiency virus (HIV).

        Results

        EA representing 7.8% (424/5453), were categorized into atypical squamous cell of undetermined significance (ASCUS) (34.4%), atypical glandular cell of undetermined significance (AGCUS) (15.3%), combined ASCUS and AGCUS (3.1%), low grade squamous intraepithelial lesions (SIL) (41.0%), high grade SIL (5.2%) and invasive lesions (1%). CGB of EA (n = 281) showed non neoplastic lesions (12.8%), atypical squamous metaplasia (ASM) (19.2%), cervical intraepithelial neoplasia I (CIN) (44.4%), CIN II (4.4%), CINIII (2.8%), endocervical lesions (5.2%), combined squamous and endocervical lesions (10.0%), invasive squamous cell carcinoma (SCC) (0.02%) and extranodal marginal zone B cell lymphoma (MZBCL) (0.02%). The overall predictive value of cytology was 87% while the predictive value for high grade lesions was 80%. On histological basis, HPVs were present in 94.3% of squamous lesions while it was difficult to be identified in endocervical ones. ISH revealed positivity for pan HPV in 65.9% of the studied biopsies (n = 217), with incorporation of the viral genome HPV 6/11, 16/18 and 31/33 in 11.1%, 33.3% and 17.1% respectively. Multiple HPVs infections were identified in 0.02%.

        Conclusion

        Pre-invasive high grade lesions and invasive cervical carcinoma represent 0.5% and 0.04% respectively in Egyptian women. HPV mostly 16/18 as a risk factor (p < 0.001), was frequently associated with mixed infections (p < 0.001) and bilharzial infestation (p < 0.001).

        Background

        In developed countries, with effective and extensive screening with Pap smears, it is usually possible to identify and treat asymptomatic precursor lesions of cacx, making it nearly 100% preventable [1]. However, five out of six women with cacx live in developing countries, and 80% of them are diagnosed at advanced stages [2]. Data from Egyptian studies provide widely varying estimates on the prevalence of pre-invasive cervical lesions ranging from 1% [3] to 8% [4] with an age range from 20–60 years. Invasive lesions represented 59.58% of all female genital tract malignancy according to Egyptian National Cancer Institute data [5]. A recent monograph from the Egyptian National Cancer Registry of seven cancer centres of the Ministry of Health and Population, reported an incidence rate for all ages ranging from 0.12% to 0.77% depending on geographical regions, being more prevalent in Lower Egypt [6]. To be stressed here, that most patients presented at late incurable clinical stages [7, 8]. Previous small hospital based series confirmed the incorporation of HPV genome in invasive lesions [8, 9]. In addition, schistosomiaisis [8, 10], and Chlamydia trachomatis (Chlamydia T) [11], has been found to be risk factors in Egyptian studies.

        In the present work we looked for HPV and other risk factors [1217] in the Egyptian population. These include viruses such as HSV-2 [16, 18], CMV [16], and HIV [17, 19]. Sexual activity with multiple sexual partners, sex with a promiscuous partner, history of sexually transmitted infections, sexual intercourse at a young age [2022], bacterial vaginosis [23], Chlamydia T [11, 24], schistosomiaisis [8, 10, 25], poor socioeconomic and low educational status [2629], risky jobs [30] and poor nutritional status [31] have also been implicated as risk factors.

        This study was the first one to be conducted in Egypt at a National level as community based full-scale cross sectional survey. The main objective was to assess the prevalence of pre-invasive and invasive cacx among Egyptian women aged between 35 and 60 years. Specifically it aimed at assessing the prevalence of biopsy-confirmed squamous, endocervical lesions and invasive cancer, identifying the preventable risk factors and exploring the knowledge and practices of the target population toward cacx screening. Therefore representative data on this problem should permit better evaluation of possible alternative approaches for the design of a national cacx prevention program.

        Methods

        Duration of the study

        The protocol was set up and approved by the funding agency "United States Agency for International Development (USAID) in January 2000. The field work started July 2000 and terminated in December 2002.

        Sampling

        Sampling design and target population

        The prevalence rates used for sample size calculations were chosen based on available data from Egyptian studies and results of recent computer modelling. A computer simulation model of incidence of cacx, based on a low risk population in the United States, suggested that the prevalence of SIL, in a previously unscreened population would be 2–3% among women 35 years old and above. The sample size estimates assume simple random sampling equal to 3012 eligible women. Assuming a design effect of 2 due to cluster sampling, the sample size needs to be doubled to be 6000. The target population was ever-married women aged 35 to 60 years. Women who were pregnant or menstruating at time of tests were excluded.

        Selection of study population

        A multi-stage sampling process was used, based on a sampling frame from the Egypt Demographic Health Survey (DHS) 2000 [32]. A sample of different regions of Egypt was made using data from the Human Development Index, which is a composite index of education, health status and living standard. Ten out of twenty six governorates were randomly chosen for the survey, representing urban/rural regions including Lower Egypt (LE), Upper Egypt (UE) and Urban governorates. From each of the sample governorates, 60 clusters of 230 households were selected that were expected to include 125 eligible women. Allowing for refusals would give about 100 women per cluster.

        Ethical considerations

        The study protocol was approved by the Ministry of Health and Population Ethical Review Board. All women were informed about the procedures of the study, the possibility of abnormalities being found, including cacx and that further invasive procedures may be necessary. Consents were obtained from the women before participation.

        Data collection

        Questionnaire

        A total of 153 questions collected data about women's background and relevant risk factors including 1- socioeconomic and general characteristics of women and their husbands, living conditions, lifestyle, marital status, menstrual and obstetric history and use of family planning, 2- current general health problems with special emphasis on schistosomiaisis, 3- gynecological health problems including personal and family history of cacx or other cancers and women and husbands' history of genital tract infections.

        Clinical and gynecological examinations

        General clinical examinations and urine laboratory test for schistosomiasis by spotting positive ova were carried out. Problems such as cystocoele, rectocoele, adnexal tenderness, or masses, uterine prolapse, cervical polyps, warts and cervical discharge, were noted and evaluated. Pap smears were taken.

        Pathological study

        Cytopathological examination

        Samples from the ectocervix and endocervix were collected using Ayer's spatula and endocervical brush and fixed onto labelled glass slides with cytospray. The cells were classified according to TBS 1991 [33]. Strict criteria were used to qualify a lesion as HPV related [34], ASCUS [34, 35], AGCUS [36], EGD [37] and to discriminate AGCUS from neoplastic endocervical cells [38] (table 1).
        Table 1

        Cytological and histological criteria used for diagnosis of cervical lesions

        Lesions

        Criteria for diagnosis

        Ref.

        Cytologic HPV

        Koilocytic atypia

        Multinucleation (frequently binucleation)

        Dyskeratosis

        Parakeratosis

        34

        ASCUS

        Nuclear enlargement approximately twice the size of an immature squamous metaplastic cell

        Slight increase in nucleo-cytoplasmic ratio

        Nuclear chromatin clumping

        Variation in nuclear size and shape including mild hyperchromasia, binucleation, and mild irregularity in the nuclear membranes

        35, 36

        AGCUS

        Nuclear enlargement approximately twice the size of an endocervical cell.

        Nuclear pseudostratification

        Mild hyperchromasia

        37

        Discriminating AGUS from neoplastic endocervical cells

        Presence of normal ECCs, singly or in sheets

        Absence of necrosis

        Absence of papillary groups

        Mild anisonucleosis

        Marked chromatin distribution

        37

        EGD

        Nuclei not cytologically malignant

        Nuclear hyperchromasia and pseudostratification

        Low mitotic figures

        Absence of papillary formation and cribriform pattern

        38

        Histologic HPV

        Koilocytic atypia: 4 points

        Binucleation: 2 points

        Dyskeratosis: one point

        Basal cell hyperplasia: one point

        Papillomatosis: one point

        Acanthosis: one point

        34

        Colposcopic-guided biopsy and Histopathology

        All EA were biopsied in an attempt to evaluate the prevalence of low/high grade dysplastic changes and invasive lesions. The received biopsies were left for 24 hours in neutral buffered formalin. Tissue embedding and processing were followed by hematoxylin and eosin (H&E) staining. The presence of bilharzial infestation was evaluated in tissue sections. Serial sections from each biopsy were classified according to the World Health Organization (WHO) for cervical neoplasia [39]. Here also strict criteria were used for histopathologic evaluation. To qualify a lesion as HPV-related, a scoring system was used for which a minimum of 6 points out of 10 were needed [34]. Data not fulfilling these criteria were classified as ASM (table 1).

        In situ hybridization for HPVs

        ISH for HPVs was effectuated for epithelial lesions starting from ASM. The materials used are summarized in table 2. Initially, HPVs were screened with the wide spectrum HPV probe recognizing genomic DNAs of HPV types 6, 11, 16, 18, 30, 31, 31, 33, 35, 45, 51 and 52. Further subtyping with HPV 6/11, 16/18 and 31/33 were performed for cases positive for pan HPV and cases negative/unsatisfactory for pan HPV but with frank HPV related lesions on conventional H&E biopsies. Positive control tissues infected with HPV were included in every ISH procedure and the technique was evaluated according to the result of this positive control. The steps for ISH are followed according to the manufacturer instructions. In brief, following deparaffinization, tissue digestion with 250–500 μl of pepsin HCl, were applied to tissue sections and the latter were incubated in 37°C oven for 10 minutes, followed by slides wash in distilled water. Denaturation and hybridization started by applying enough drops of the probe to tissue sections, coverslipping, laying the slide on pre-warmed slide warmer, and incubation in 37°C oven for 60 minutes. Slides were immersed in Tris buffer to remove covers, washed and immersed in warm stringent wash, incubated in 37°C oven for 30 minutes, and then washed in Tris buffer. For revelation, streptavidin alkaline phosphatase was applied to sections for 20 minutes. Slides were washed in Tris buffer twice. BCIP/NBT were applied to sections and incubated in dark for 60 minutes, followed by wash in Tris buffer twice. Slides were lastly washed distilled water and mounted using aqueous media. Positive signals were seen as dark blue dots in the affected nuclei.
        Table 2

        Reagents used in the study

        Reagents

        Source

        code

        ISH detection kits and probes

        ISH detection system

        Dako

        K0601

        Wide spectrum HPV

        Dako

        Y1404

        6/11 HPV

        Dako

        Y1411

        16/18 HPV

        Dako

        Y1412

        31/33 HPV

        Dako

        Y1413

        IHC detection kits and antibodies

        LSAB-2 Detection kit

        Dako

        K0680

        HSV- 2

        Dako

        B0116

        CMV early antigens

        Novocastra

        NCL- CMV- EA

        CMV late antigens

        Novocastra

        NCL- CMV- EA

        P 24 capsid protein

        Novocastra

        NCL-p24

        Immunohistochemistry

        Immunohistochemistry (IHC) was effectuated for equivocal cases negative for HPV and cases with histological suspicion for infections with HSV-2 or CMV. In these instances, HSV-2, early and late CMV antigens were assessed. For other viral lesions not proven cytologically, histologically or by IHC to be HSV-2 or CMV infection, p24 capsid proteins for HIV was used. In addition, cytokeratin, leucocyte common antigen and CD79a were used to diagnose an extranodal MZBCL. The materials used are summarized in table 2. The steps of IHC are followed according to the manufacturer instructions. All incubations were performed at room temperature. Tris buffer was used for washing. In brief, following deparaffinization, the endogenous peroxidase activity was quenched by 0.3% hydrogen peroxide for 5 minutes followed by washing. Primary antibodies diluted at 1/50, were incubated for 30 minutes, then slides were rinsed in successive buffer bathes. The revelation was done with LSAB-2 detection kit. Finally, diaminobenzidine tetrachloride (DAB) was applied for 5 minutes. Slides were counterstained in Harris haematoxylin (Hx), dehydrated, cleared in xylene and coverslipped. Tissues infected with HSV-2, CMV and p24 were used as positive control while replacement of the antibodies by Tris buffer was used as negative control for the procedure. IHC results were evaluated either as positive or negative.

        Statistical analysis

        Lesions were grouped according to histological results into: 1- normal without epithelial changes, 2- ASM, 3- low grade lesions including CINI with or without HPV and EGD alone or combined with either ASM or CINI, 4- High grade lesions including CINII, CINIII/CIS alone or combined with EGD and adenocarcinoma in situ (AIS), and 5- Invasive lesions. A cut-off point of 45 years was used to categorize two aged groups 35–45 and >45–60 years. SPSS version 9 was used for statistical analysis. Descriptive analysis was made of demographic, cytology and follow up CGB data. Cross tabulations with significance tests and Odd Ratio (OR) with 95% confidence interval (CI) were made. Multivariate analysis was carried out to estimate the main determinant risk factors for cacx in the study population.

        Quality control

        A pilot study was carried out to test methods of obtaining community cooperation and reactions of respondents to the research procedures and their desire to participate. All staff members were trained to ensure standardization of methods. A written operational manual explaining in details how to perform Pap smear and CGB and all staining steps was prepared. Random re-screening of 20% of the Pap smear and all EA was done for every cluster, in addition to the strict criteria used for evaluating abnormal lesions and was assessed by kappa test.

        Results

        History cervical cancer and awareness of the risk factors

        Twelve women (0.2%) had a female relative diagnosed as cacx. Less than 2%, mostly from urban areas, had ever had Pap smear with normal results in 77% of them. Only three women mentioned having dysplastic/atypical changes before, however these finding were not documented by cytopathological reports and their Pap smears were normal in the present study. Only 2% could identify smoking, hormones, and infection as risk factors but not HPV.

        Cytopathology

        The total number of Pap smears studied was 5658. However, 5453 women with complete data were included in the study (97%). Unsatisfactory results were present in 195 smears (3%), mostly due to absence of endocervical/transformation zone and poor fixation in 66.15% and 16.92% respectively, and were more pronounced in the first three governorates. Two third of the women had inflammatory changes (63%), while epithelial abnormalities were identified among 8%.

        Inflammatory and Reparative Changes

        All the inflammatory smears were associated with reparative changes including reserve cells hyperplasia, early immature squamous metaplastic cells, cells merging to maturation and fully mature cells. This process was more pronounced in association with IUD devices. Three smears showed mature reparative changes only, probably representing post inflammatory squamous metaplasia. The most common infection was bacterial (49%) (figure 1).
        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig1_HTML.jpg
        Figure 1

        Inflammatory changes.

        Epithelial abnormalities according to TBS

        Epithelial changes were found in 424 women (8%), more commonly among LE women (9%) and less commonly in rural UE (6%); one-third of these cases were among urban governorates residents (p < 0.005). The most common type was LGSIL including HPV infection (41%) (figure 2). HGSIL was found in 22 women (5%). Cytological features highly suggestive of invasive carcinoma were diagnosed in four cases. Table 3 illustrates the EA.
        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig2_HTML.jpg
        Figure 2

        LGSIL HPV associated showing koilocytic atypia (A), binucleation (B) and dyskeratosis (C) Papanicolaou stain, × 40.

        Table 3

        Percentage distribution of women by cytological epithelial abnormalities according to place of residence

        Epithelial

        Urban

        LE

        UE

        P

        Total

        abnormalities

        governorates

        Urban

        Rural

        Urban

        Rural

        Freq.

        %

        Atypical

                

           ASCUS

        37.2

        27.3

        35.2

        46.3

        26.7

         

        146

        34.4

           AGCUS

        14.9

        14.5

        16.2

        29.3

        8.0

         

        65

        15.3

           Combined

        1.4

        1.8

        4.8

        2.4

        5.3

         

        13

        3.1

              

        <0.05

          

        Squamous lesions

                

           LGSIL

        41.2

        43.6

        37.1

        12.2

        60.0

         

        174

        41.0

           HGSIL

        4.7

        10.9

        5.7

        7.3

        0.0

         

        22

        5.2

        Invasive

                

           Squamous

        0.0

        1.8

        0.0

        2.4

        0.0

         

        2

        0.5

           Endocervical

        0.7

        0.0

        1.0

        0.0

        0.0

         

        2

        0.5

        Total

        148

        55

        105

        41

        75

         

        424

         

        Histological evaluation of CGB

        CGB was recommended for all women with EA (424 ones). A total of 281 ones (66%) were available. Unsatisfactory biopsies were encountered in 30 cases (10.67%); the most common cause was absence of endocervical tissue in a lesion previously diagnosed as AGCUS (62%), and was more obvious in earlier governorates. The histological results are summarized in table 4. The strict criteria used for evaluating HPVs histologically enabled us to categorize squamous lesions with or without HPV infection (table 5). However, there were no valid criteria for identification of HPVs in endocervical lesions, making ISH a premium for diagnosis of HPVs infected endocervical lesions. The overall predictive value of cervical cytology was 87% with values of 90.10%, 86.68%, 80% and 78.13% for LGSIL, ASCUS, HGSIL and AGCUS respectively. Figures 3, 4 and 5 illustrate cyto-histologic correlation of some cases.
        Table 4

        Histological results and pan HPV ISH of CGB

        Results

        Histology

        Pan HPV ISH

        Freq.

        %

        Negative

        Positive

        NS

        Normal

        32

        12.8

        ND

        ND

        ND

        ASM

        48

        19.2

        39

        6

        3

        CIN

             

        CINI

        111

        44.4

        16

        89

        6

        CINII

        11

        4.4

        2

        9

        0

        CINIII/CIS

        7

        2.8

        0

        7

        0

        Glandular lesions

             

        EGD

        12

        4.8

        4

        8

        0

        AIS

        2

        0.8

        0

        1

        1

        Combined dysplasia

             

        ASM + EGD

        4

        1.6

        2

        2

        0

        CINI+EGD

        18

        7.2

        0

        17

        1

        CINII+EGD

        2

        0.8

        0

        2

        0

        CINIII+EGD

        1

        0.4

        0

        1

        0

        Invasive

             

        Invasive carcinoma

        1

        0.4

        0

        1

        0

        Lymphoma

        1

        0.4

        ND

        ND

        ND

        Total

        250

        100

        63 (29.0%)

        143

        11

            

        (65.9%)

        (5.1%)

           

        217 (86.8%)

        ND: not done NS: non significant

        Table 5

        Histological evidence of HPVs infection in neoplastic squamous lesions

         

        Freq.

        Histologic evidence of HPV

        %

        CIN I

        111

        104

        93.7

        CINII

        13

        12

        92.3

        CINIII

        7

        6

        85.7

        Combined dysplasia

        25

        25

        100.0

        Invasive carcinoma

        1

        1

        100.0

        Total

        157

        148

        94.3

        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig3_HTML.jpg
        Figure 3

        Combined dysplasia, A- ASCUS, the nucleus is twice the size of the left intermediate cell on the right, Pap stain, ×40. B- Another area showing nuclear pseudostratification and loss of the normal honey combing, Pap stain, ×40. C- A third area showing ASCUS and AGCUS in the same field, Pap stain, ×40. D- Glandular colonization by the neoplastic cells and dysplastic endocervical lining, H&E, ×10. E- Higher power magnification of the colonized glands showing koilocytes, increased nucleo-cytoplasmic ratio and large nucleolated nuclei, H&E, ×40. F- Higher power magnification of the endocervical dysplastic cells, H&E, ×40. G- Another field showing colonization of the glands by the koilocytes and residual normal endocervical cells, H&E staining, ×40. H- Surface epithelium showing koilocytic atypia, acanthosis, papillomatosis and basal cell hyperplasia, H&E, ×40.

        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig4_HTML.jpg
        Figure 4

        A- AGCUS favoring a neoplastic process, Pap stain, × 400. B- AIS, H&E staining, ×20.

        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig5_HTML.jpg
        Figure 5

        LCNK SCC, A- Fibres cells (arrow) and koilocytes (arrow head), Pap stain, × 400. B- Marked nuclear pleomorphism and hyperchromasia and heavy neutrophilic infiltrate, Pap stain, × 400. C- Corresponding biopsy: islands of neoplastic cells surrounded by heavy neutrophilic infiltrate, H&E, ×10

        IHC results

        Only one case cytologically diagnosed as ASCUS, was positive for HSV-2. All suspicious cases tested for CMV and HIV infections were negative by IHC. Accidentally, one case positive for leukocyte common antigen and CD79a was classified as extranodal MZBCL.

        Prevalence of HPV and cervical lesions

        ISH using pan HPV probe tested on 217 cases, was positive among 66%, negative in 29% and non significant in 5% of cases (figures 6, 7 and 8). The prevalence of cervical lesions in the studied population is summarized in tables 6 while that of HPV in the tested abnormal biopsies is illustrated in table 7. The viral genome for HPV 6/11, 16/18 and 31/33 was incorporated in 11.1%, 33.3% and 17.1% respectively in the studied biopsies (table 8). Interestingly, 12.5% (6/48) of ASM were HPV positive.
        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig6_HTML.jpg
        Figure 6

        CINIII, A- H&E, × 20. B- HPV nucleic acid, ISH, pan HPV probe, × 20.

        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig7_HTML.jpg
        Figure 7

        EGD, A- EGD, ISH, pan HPV probe, ×10. B- Higher power magnification showing variable degree of intensity with severe intensity in the middle zone, ×40.

        http://static-content.springer.com/image/art%3A10.1186%2F1750-9378-2-12/MediaObjects/13027_2007_Article_21_Fig8_HTML.jpg
        Figure 8

        LCNK SCC A-, H&E, ×20. B- HPV nucleic acid in almost all the cells. ISH, pan HPV probe, × 20

        Table 6

        Prevalence of cervical lesions in the Egyptian population (n = 5453)

        Cervical lesions

        Freq.

        %

        CINI

        111

        2.04

        CIN I+EGG

        18

        0.30

        CINII

        13

        0.24

        CIN II+EGG

        2

        0.03

        CINIII

        7

        0.13

        CINIII + EGD

        1

        0.02

        EGD

        12

        0.22

        AIS

        1

        0.02

        SCC

        1

        0.02

        Total

        166

        3.04

        Table 7

        Prevalence of HPV infection in the tested population (n = 217)

        HPV infections

        Freq.

        %

        Pan HPV

        143

        65.9

        HPV 6/11

        24

        11.1

        HPV 16/18

        68

        31.3

        HPV 31/33

        37

        17.1

        Table 8

        HPVs in high grade cervical lesions

        High grade cervical lesions

        HPV

        Total

        Pan

        6/11

        16/18

        31/33

        Neg/Pos

        Neg/Pos

        Neg/Pos

        Neg/Pos

        CINII

        2/11

        13/0

        6/7

        8/5

        13

        CIN II+EGG

        0/2

        2/0

        0/2

        2/0

        2

        CINIII

        0/7

        7/0

        1/6

        6/1

        7

        CINIII + EGD

        0/1

        1/0

        0/1

        0/1

        1

        SCC

        0/1

        1/0

        0/1

        1/0

        1

        AIS

        1/0

        1/0

        1/0

        1/0

        1

        Total

        3/22

        25/0

        8/17

        18/7

        25

        Risk factors of cervical lesions

        Risk factors of ASM were infection with HPV especially subtypes 16/18 and 31/33 and ever usage of vaginal contraceptives (p <0.0001 for each). The risk factors for low grade CIN are still menstruating (p <0.001), working (p <0.0001), HPV infection with the three probes studied 6/11, 16/18 and 31/33 (p <0.000 for each), while for high grade CIN infection, with HPV mainly subtypes 16/18 and 31/33 (p <0.001) was the common threat. Multiple regression analysis revealed that being a working woman (OR 2.0, 95% CI 1.3–3.1) and still menstruating (OR 1.5, 95% CI 1.1–2.1) were the main risk factors.

        HPVs infection were more pronounced in younger age, actually married, still menstruating and ever used hormonal or vaginal contraceptives (p <0.05 for each), and unskilled workers (p <0.0001). In addition, there was an increasing positivity rate for HPV with increasing lesion severity. Applying multiple regression analysis revealed that being a working woman (OR 2.0, 95% CI 1.3–3.2), still menstruating (OR 1.6, 95% CI 1.1–2.3) and women who ever had hormonal contraception (OR 1.5, 95% CI 1.1–2.1) were the main determinants for HPV infection. HPV infection seemed to be more among women whose husbands ever had another wife or travelled before, however this finding was not statistically significant.

        Discussion

        HPV has been recognized as the necessary cause of cervical cancer [2]. However, in the present study, awareness of HPV as major risk factor for cacx was very low among the studied population while smoking, hormones, and infections were identified as main risk factors. Previous studies approaching this point came out with the same conclusion of ignorance of association between HPV and cacx [40, 41]. As expected, only 1.5% of studied women, mostly from urban areas, had Pap smear. Three of them mentioned, without documents, having results consistent with invasive lesions. However, their cytological results were normal in this study. This important point highlights the absence of health culture in the population. Studies from other countries, reported that only 5% of women in low and middle income countries received screening, usually in private clinics and few urban settings, contrary to high-income countries where up to 70% of women were screened [1, 42].

        ASM cases were positive for HPV 16/18 and 31/33. ASM, a poorly characterized cervical lesion with uncertain biological and clinical significance, shares some but not all morphological features of SIL [43, 44]. It has been shown that HPV positive ASM biopsies were significantly more likely to have concurrent or subsequent diagnosis of HSIL than HPV negative ones [43, 45]. Unfortunately, the actual study is limited by the fact that it covers a single period and had no opportunity to follow up ASM HPV positive cases. The rational for inclusion of ASM was based on the fact that recent studies found HPVs genome incorporated in normal squamous epithelium [22, 46, 47]. However, due to financial restraints, normal tissues were not included, to evaluate the presence/absence of HPVs.

        This community based study confirms previous hospital based one reporting low prevalence rate for CIN; analysis of 4458 patients showed a prevalence of 0.36%, 0.23% and 0.12% for CINI, CINII and CINII respectively [48]. In addition, the Middle East Cancer Consortium reported 0.027% prevalence rate for cacx for Egyptian women [49]. The prevalence of EA and HPV infections in Egypt is comparable to other geographical areas in Muslim and Middle East countries. In Saudi Arabia, EA represented 3.14% out of 3088 screened women with ASCUS, LGSIL, HGSIL, invasive SCC, AGCUS and adenocarcinoma represented 0.45%, 0.93%, 0.55%, 0.13%, 0.13% and 0.03% respectively [50]. In Jordan a prevalence of 0.026% has been reported [49]. In Lebanon, a study conducted on 1,026 women revealed a prevalence of 4.9% for HPV with type 16 representing 3% [51]. In Morocco, 70.5% of invasive carcinoma cases were HPV positive, 34.88% cases had HPV16, and 15.5% cases had HPV18 [52]. In Iran, controversial data were reported; 73.9% of HPV positive cacx contained HPV16 [53], while in another study HPV16 was identified in 26.7% and none of the samples were positive for HPV18 [54].

        Studies showed significant geographic variation in the prevalence of oncogenic viral types in cervical lesions with roughly half of all cacx worldwide containing HPV 16. Other important high risk types are HPV 18, 45, and 31. Less prevalent high risk types include HPV 26, 33, 35, 39, 51, 52, 56, 58, 59, 68, 73, and W13b [47]. In Africa, the most common subtype is HPV 16 followed by 45, 18, 31 and 33 [55], a point concordant with the actual work. Unskilled workers were at greater risk for HPV infection and other EA. These women were the highest to have husbands with history of genital infection, showed vaginal discharge by examination, reported history of infection and higher sexual activity. HPV infection seemed to be more among women whose husbands ever had another wife or travelled before. In addition, one fourth of unskilled workers had husbands who ever travelled before or married another wife. In spite that the majority of women had married once, 15% of unskilled workers had married more than once. It is clear that the marital/sexual practices of unskilled workers were the determinants of their higher susceptibility to HPV and CIN. The socio-economic characteristics of unskilled workers confirm previous studies where associations have been found between low socioeconomic status [1, 28, 26], multiple sexual partners [5659] and cacx. Another risk factor, smoking, is added to unskilled workers, as 83% of them were exposed to smoking at home and work. Higher prevalence for high-risk HPV types was significantly associated with cigarette smokers [60]. Steroid contraception has been postulated to be one mechanism whereby HPV exerts its oncogenic effect on cervical tissue especially among long-term users [61], a point concordant with the present study, mostly noted in one half of unskilled workers. The prevalence of HPV in ASM and other abnormal biopsies may be underestimated due to the fact that the HPV probes used in the study do not cover all the high risk types and include some low risk [47]. Additionally, normal tissues previously shown to harbour the virus [22, 46, 47] were not tested due to financial limitations. A third important point is the use of ISH technology, an insensitive one compared to catalyzed signal amplified colorimetric DNA ISH [62], to hybrid capture (HC) HPV DNA assay [6365] or polymerase chain reaction [66, 67]. However, other studies showed that ISH HPV was more predictive of biopsy histopathology in patients with detectable cervical lesions than is HC HPV [68]. Furthermore, the sensitivity of ISH was comparable to that of HC2, with significantly superior specificity, and was therefore thought to be an efficacious alternative to HC2 for triaging patients with abnormal cervical cytology results [69].

        Our data on schistosomiaisis as risk factor for the development of cacx confirm previous studies in Egypt [8, 10] and elsewhere [25]. However, T. vaginalis previously implicated to have direct relation to cacx in the Egyptian population [11] were not established in the actual work. Moreover, early marriage or early sexual relations, was not significantly associated with HPV as Egyptian women start sexual relations with marriage. Other studies confirmed that women who have their first intercourse at an early age are at high risk for HPV infection and cacx [56, 57, 70]. Being uncircumcised male was found to be a high risk factor [59], which was not evaluated due to universality of male circumcision among Egyptian men both Moslem and Christians.

        The study is limited by the fact that it covers a single period and had no opportunity to examine trends over time. Three obstacles reduced the number of satisfactory smears, noted mostly at the beginning of the study, implying the importance of training. These were, smears not interesting the squamo-columnar junction, inadequate fixation and hemorrhagic smears resulting from traumatisation of the mucosa by the cytobrush. Inadequate biopsies were encountered whenever they were performed in health units using portable colposcope. In addition, women of higher socioeconomic group refusal to participate may have led to missing the chance to describe the pattern of cervical lesions among this group. The drop out of women for CGB was due to their refusal to participate in spite of counselling. Concerning HPVs ISH, two points should be discussed. The first was fixation more than 24 hours in UE specimens, a point that may explain the negativity for all HPVs probes even with the presence of frank HPVs in biopsies. The second was the limited number of tested probes compared to the known HPVs subtypes. Cultural sensitivity for sexual relationships in the Egyptian community in general and among women specifically, made it difficult to get detailed information even with using probing questions for assessing sexually transmitted infections.

        In conclusion, this study is the first one at a national level describing the characteristics of women with cervical epithelial abnormalities. They were mostly of middle income, married, with three and more children, mostly uneducated and not working. The awareness of the Egyptian women by risk factors or symptoms of different reproductive health problems are extremely low. Prevalence of CIN and invasive lesions was 3.1% and 0.04%, while the prevalence of HPVs was 2.6% and was positive in 94.3% of cervical lesions confirming that it is the main causing agent. The study recommends introducing cacx screening for all women at least once every 10 years for women with normal cytological findings, and yearly for three successive years for inflammatory changes. CGB should be performed to all EA to avoid losing patients and subsequently tumor progression. In addition, raising awareness of Egyptian women on reproductive health and risk factors of cacx through specially designed health communication programs is mandatory.

        Abbreviations

        AGCUS: 

        atypical glandular cells of undetermined significance

        AIS: 

        adenocarcinoma in situ

        ASCUS: 

        atypical squamous cells of undetermined significance

        ASM: 

        atypical squamous metaplasia

        Cacx: 

        cancer cervix

        Chlamydia T: 

        Chlamydia trachomatis

        CIN: 

        cervical intraepithelial neoplasia

        EA: 

        epithelial abnormalities

        EGD: 

        endocervical glandular dysplasia

        HGSIL: 

        high grade squamous intraepithelial lesion

        HPVs: 

        human papilloma viruses

        IHC: 

        Immunohistochemistry

        ISH: 

        in situ hybridization

        LGSIL: 

        low grade squamous intraepithelial lesion

        Pap smears: 

        Papanicolaou smears

        TBS: 

        the Bethesda System

        SCC: 

        squamous cell carcinoma.

        Declarations

        Acknowledgements and Collaborators

        The study was carried out by the Faculty of Medicine Suez Canal University in collaboration with the Research Management Unit of the National Population Council and sponsored by the USAID/Cairo. The authors are grateful to Prof. Mohammed Fayaad, Professor of Gynecology, Prof. Adly Farid Ghaly and Prof. Nadia Mokhtar, Professor of Pathology, for their excellent and valuable comments all over the study. We are indebted to other members of the Faculty participating in the Project; the Gynecology Team, Professor Galal Lotfy, and Doctors Rasha El Saied, Marium Lotfy, Abeer Bahaa, Amal Saied, Nahed Amin, Mona Fathy, Thuria Ahmed, Mona Galal Eldine, Soheir Abdelghafar and Kawser Abdelazeim, Assistant Lecturers of Obstretrics and Gynecology; the colposcopy team, Doctors Mohamed Shaban, Yaser Habash, Mosaad Abdelhamid, Mohamed Abouelsood and Mohey Mohamed; the pathology team, Doctors Maha Rashwan and Hala Abd El Dayem Assistant Lecturers and Magdy El Korachy, Demonstrator; field work team, Doctors Aymen Farghaly, Rasha Farouq, Hatem Salam and Yasser Youssef, Community Medicine and Tamer Abdel Fatah, Microbiology, Demonstrators. The cooperative assistance of the cytopathologists Professors Leila Nabegh, Magda Abd El Salam, Zeinab Chegab Eldine and Rageya Ahmed at Ain Shams University is appreciated. We are gratefull to the enormous great effort of the Pathology Technicians Fatouh Arafa, Mohammed El Seify, Sayed Chaheen, Mohammed Saeed, Nahla Abd El Reheem, Cherine Faroouk, Mohammed El Cherbeeny, Sayed Gareeb and Zeinab Ahmed. The secretarial assistance of Rabaab Metwally was very helpfull. Special thanks to the health units' directors, interviewers, listing personal, social workers and nurses. This study wouldn't take place without the help and encouragement of our ex Dean Professor Mohammed Abd El Kafy and our actual Dean Professor Mohamed Shoeir.

        Authors’ Affiliations

        (1)
        Howayda S Abd El All, Principal Investigator for Pathology, Department of Pathology, Faculty of Medicine Suez Canal University
        (2)
        Department of Community Medicine, Principal Investigator for Data Management, Faculty of Medicine Suez Canal University
        (3)
        Department of Community Medicine, Principal Investigator for Field Work, Faculty of Medicine Suez Canal University

        References

        1. Murray CJL, Lopez AD: Global health statistics. Boston, Harvard School of Public Health on behalf of WHO and the World Bank 1996.
        2. Stewart BW, Kleihues P: Cancers of the female reproductive tract. In WHO Cancer Report. Lyon, France. IARC; 2003:215–222.
        3. El Mosselhy MH, Moselhy MM, Amin A, Ouda-Pasha E, Abdel Hamid, Hussein MH: Prevelance of reproductive tract infections among married women of reproductive age. National Population Council/El Galaa Teaching Hospital, Egypt; 1998.
        4. Younis N, Khattab H, Zurayk H, el-Mouelhy M, Amin MF, Farag AM: A community study of gynecological and related morbidities in rural Egypt. Stud Fam Plann 1993, 24:175–186.View ArticlePubMed
        5. Mokhtar N: Cancer Pathology Registry 1985–1989. Department of Pathology. NCI, Cairo, Egypt; 1991.
        6. National Cancer Registry: The National Cancer Registry Newsletter. Ministry of Health and Population, Egypt; 2002.
        7. Abd El All H, Nada G, Awaad HK, El Ayaat A: Natural killer cells in human cervical carcinoma. Master Degree Thesis, Suez Canal University, Ismailia, Egypt; 1987.
        8. Abd El All H, Prade M, Khatab T, Awaad HK, Ghaly AF: Immunological study of NK cells in cervical carcinoma. In Ph.D. Thesis. Faculty of Medicine, Suez Canal University, Ismailia, Egypt; 1992.
        9. Ahmed MI, Salahy EE, Fayed ST, El-Hefnawy NG, Khalifa A: Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha. Clin Biochem 2001, 34:491–498.View ArticlePubMed
        10. Youssef AF, Fayad MM, Shafeek AED: Bilharziasis of the cervix uteri. BJOG 1970, 77:847–851.View Article
        11. Sayed el-Ahl SA, el-Wakil HS, Kamel NM, Mahmoud MS: A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women. J Egypt Soc Parasitol 2002, 32:167–178.PubMed
        12. Zur Hausen H: Intracellular surveillance of persisting viral infections. Lancet 1986, 30:489–491.View Article
        13. Zur Hausen H: Papilloma viruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989, 49:4677–46851.PubMed
        14. Zur Hausen H: Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996, 1288:55–78.
        15. Zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000, 92:690–698.View ArticlePubMed
        16. Han CP, Tsao YP, Sun CA, Ng HT, Chen SL: Human papillomavirus, cytomegalovirus and herpes simplex virus infections for cervical cancer in Taiwan. Cancer Lett 1997, 120:217–221.View ArticlePubMed
        17. Rezza G, Giuliani M, Branca M, Benedetto A, Migliore G, Garbuglia , D'Ubaldoc C, Pezzotti P, Cappiello G, Pomponi-Formiconi D, Suligoi B, Schiesari G, Giocomini G: Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol 1997, 13:937–943.View ArticlePubMed
        18. Viikki M, Pukkala E, Nieminen P, Hakama M: Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol 2000, 39:71–75.View ArticlePubMed
        19. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Birk P: Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91:226–236.View ArticlePubMed
        20. Lovejoy NC: Precancerous and cancerous cervical lesions: the multicultural "male" risk factor. Oncol Nurs Forum 1992, 21:497–504.
        21. Bosch FX, Castellsague X, Munoz N, de Sanjose S, Ghaffari AM, Gonzalez LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, Guerrero E, Shah KV: Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996, 88:1060–1067.View ArticlePubMed
        22. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55:244–265.PubMed
        23. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M: A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002, 94:1406–1414.PubMed
        24. Markowska J, Fischer N, Fischer Z, Warchol JB: Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status. Eur J Gynaecol Oncol 2002, 23:511–513.PubMed
        25. Moubayed P, Ziehe A, Peters J, Mwakyoma H, Schmidt D: Carcinoma of the uterine cervix associated with schistosomiasis and induced by human papillomaviruses. Int J Gynaecol Obstet 1995, 49:175–179.View ArticlePubMed
        26. de Sanjose S, Bosch FX, Munoz N, Tafur L, Gili M, Izarzugaza I, Izquierdo A, Navarro C, Vergara A, Munoz MT, Ascunce N, Shah KV: Socioeconomic differences in cervical cancer: two case-control studies in Colombia and Spain. Am J Public Health 1996, 86:1532–1538.View ArticlePubMed
        27. de Sanjosé S, Bosch FX, Muñoz N, Shah K: Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997, 138:309–317.PubMed
        28. Mackillop WJ, Zhang-Salomons J, Boyd CJ, Groome PA: Associations between community income and cancer incidence in canada and the united states. Cancer 2000, 89:901–912.View ArticlePubMed
        29. Wellensiek N, Moodley M, Moodley J, Nkwanyana N: Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. Int J Gynecol Cancer 2002, 12:376–382.View ArticlePubMed
        30. Weiderpass E, Pukkala E, Vasama-Neuvonen K, Kauppinen T, Vainio H, Paakkulainen H, Boffetta P, Partanen T: Occupational exposures and cancers of the endometrium and cervix uteri in Finland. Am J Ind Med 2001, 39:572–580.View ArticlePubMed
        31. Ramaswamy G, Krishnamoorthy L: levels in breast cancer and cancer of the uterine cervix. Nutr Cancer 1996, 25:173–177.View ArticlePubMed
        32. El Zanaty F, Way A: EDHS 2000: Egypt Demographic and Health Survey, Ministry of Health and Population. National Population Council, Egypt; 2001.
        33. Solomon D: The Bethesda System for reporting cervical/vaginal cytologic diagnosis: an overview. Int J Gynecol Pathol 1991, 10:323–325.View ArticlePubMed
        34. Concensus morphologique sur les néoplasies du coluterin. Paris-TolbiacArchives d'Anatomie et de Cytologie Pathologiques 1991, 39:186–222.
        35. Malik SN, Wilkinson EJ, Drew PA, Bennet BB, Hardt NS: Do qualifiers of ASCUS distinguish between low- and high risk patients? Acta Cyto 1999, 43:376–380.
        36. Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A: Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear. Acta Cytol 2000, 44:576–586.PubMed
        37. Casper GR, Ostor AG, Quinn MA: A clinicopathologic study of glandular dysplasia of the cervix. Gynecol Oncol 1997, 64:166–170.View ArticlePubMed
        38. Cenci M, Mancini R, Nofroni I, Vecchione A: Endocervical atypical glandular cells of undetermined significance. I. Morphometric and cytologic characterization of cases that "cannot rule out adenocarcinoma in situ". Acta Cytol 2000, 44:319–326.PubMed
        39. Tavassoli FA, Devilee P: Pathology and Genetics. Tumors of the breast and female genital organs. WHO classification of tumours 2003., 6:
        40. Pitts M, Clarke T: Human papillomavirus infections and risks of cervical cancer: what do women know? Health Educ Res 2002, 17:706–714.View ArticlePubMed
        41. Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J: Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003, 79:320–322.View ArticlePubMed
        42. Miller AB, Nareer S, Fonn S, Brandup-Lukanon A, Rakshanda R, Cronje H, Sankaranarayanan R, Korolcltchouk , Syrjanen K, Singer A, Onsrud M: Report on consensus conference on cervical cancer screening and management. Int J Gyn Obst 2000, 86:440–447.
        43. Geng L, Connolly DC, Isacson C, Ronnett BM, Cho KR: Atypical immature metaplasia (AIM) of the cervix: is it related to high-grade squamous intraepithelial lesion (HSIL)? Hum Pathol 1999, 30:345–351.View ArticlePubMed
        44. Park JJ, Genest DR, Sun D, Crum CP: Atypical immature metaplastic-like proliferations of the cervix: diagnostic reproducibility and viral (HPV) correlates. Hum Pathol 1999, 30:1161–1165.View ArticlePubMed
        45. Quddus MR, Zhang S, Sung CJ, Liu F, Neves T, Struminsky J, Singer DB: Utility of HPV DNA detection in thin-layer, liquid-based tests with atypical squamous metaplasia. Acta Cytol 2002, 46:808–812.PubMed
        46. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA: Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999, 281:1605–1610.View ArticlePubMed
        47. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KS, Snijders PJF, Chris JLM, Meijer CJLM, the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. New England J Medicine 2003, 348:518–527.View Article
        48. Hammad MM, Jones HW 3, Zayed M: Low prevalence of cervical intraepithelial neoplasia among Egyptian females. Gynecol Oncol 1987, 28:300–304.View ArticlePubMed
        49. Komoditi C: Cervical and Corpus Uterine Cancer. In Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. Edited by: Freedman LS, Edwards BK, Ries LA, Young JL. National Cancer Institute. NIH Pub. No. 06–5873. Bethesda, MD; 2005:83–90.
        50. Altaf FJ: Pattern of cervical smear cytology in the western region of Saudia Arabia. Annals Saudi Med 2001, 21:94–96.
        51. Mroueh AM, Seoud MA, Kaspar HG, Zalloua PA: Prevalence of genital human papillomavirus among Lebanese women. Eur J Gynaecol Oncol 2002, 23:429–432.PubMed
        52. Lalaoui K, El Mzibri M, Amrani M, Belabbas MA, Lazo PA: Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control. Clin Microbiol Infect 2003, 9:144–148.View ArticlePubMed
        53. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A: The Prevalence of Human Papillomavirus in Cervical Cancer in Iran. Asian Pac J Cancer Prev 2003, 3:69–72.
        54. Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP, Ghaderi A: High risk HPV types in southern Iranian patients with cervical cancer. Pathol Oncol Res 2003, 9:121–125.View ArticlePubMed
        55. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S: Human Papilloma virus types in invasive carcinoma worldwide: a meta-analysis. Br J Cancer 2003, 88:63–73.View ArticlePubMed
        56. Williams MA, Kenya PR, Mati JK, Thomas DB: Risk factors for invasive cervical cancer in Kenyan women. Int J Epidemiol 1994, 23:906–912.View ArticlePubMed
        57. Biswas LN, Manna B, Maiti PK, Sengupta S: Sexual risk factors for cervical cancer among rural Indian women: a case-control study. Int J Epidemiol 1997, 26:491–495.PubMed
        58. Murthy NS, Mathews A: Risks for pre-invasive lesions of the cervix. Eur J Cancer Prev 2000, 9:5–14.View ArticlePubMed
        59. Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ: Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002, 78:215–218.View ArticlePubMed
        60. Roteli-Martins CM, Panetta K, Alves VA, Siqueira SA, Syrjanen KJ, Derchain SF: Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand 1998, 77:678–682.View ArticlePubMed
        61. Moodley M, Moodley J, Chetty R, Herrington CS: The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 2003, 13:103–110.View ArticlePubMed
        62. Birner P, Bachtiary B, Dreier B, Schindl M, Joura EA, Breitenecker G, Oberhuber G: Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions. Mod Pathol 2001, 14:702–709.View ArticlePubMed
        63. Roteli-Martins CM, Alves VA, Santos RT, Martinez EZ, Syrjanen KJ, Derchain SF: Value of morphological criteria in diagnosing cervical HPV lesions confirmed by in situ hybridization and hybrid capture assay. Pathol Res Pract 2001, 197:677–682.View ArticlePubMed
        64. Hesselink AT, van den Brule AJ, Brink AA, Berkhof J, van Kemenade FJ, Verheijen RH, Snijders PJ: Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 2004, 102:11–18.View ArticlePubMed
        65. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J: New Technologies for Cervical Cancer Working Group. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 2006, 98:765–774.View ArticlePubMed
        66. Lie AK, Skjeldestad FE, Hagen B, Johannessen E, Skarsvag S, Haugen OA: Comparison of light microscopy, in situ hybridization and polymerase chain reaction for detection of human papillomavirus in histological tissue of cervical intraepithelial neoplasia. APMIS 1997, 105:115–120.View ArticlePubMed
        67. Lie AK, Isaksen CV, Skarsvag S, Haugen OA: Human papillomavirus (HPV) in high-grade cervical intraepithelial neoplasia (CIN) detected by morphology and polymerase chain reaction (PCR): a cytohistologic correlation of 277 cases treated by laser conization. Cytopathology 1999, 10:112–121.View ArticlePubMed
        68. Qureshi MN, Rudelli RD, Tubbs RR, Biscotti CV, Layfield LJ: Role of HPV DNA testing in predicting cervical intraepithelial lesions: comparison of HC HPV and ISH HPV. Diagn Cytopathol 2003, 29:149–155.View ArticlePubMed
        69. Qureshi MN, Bolick D, Ringer PJ, Spagler FL, Zimmerman G: HPV testing in liquid cytology specimens: comparison of analytic sensitivty and specificity for in situ hybridization and chemiluminescent nucleic acid testing. Acta Cytol 2005, 49:120–126.PubMed
        70. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD: The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women. J Pediatr 2002, 141:718–723.View ArticlePubMed

        Copyright

        © Abd El All et al. 2007

        This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

        Advertisement